SYNTHESIS AND FUNCTIONAL-EVALUATION OF A PEPTIDE DERIVATIVE OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE

被引:17
作者
BALAJTHY, Z
ARADI, J
KISS, IT
ELODI, P
机构
[1] Department of Biochemistry, Medical University of Debrecen, H-4012 Debrecen
关键词
D O I
10.1021/jm00096a006
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We have synthesized a peptidyl prodrug derivative of 1-beta-D-arabinofuranosylcytosine (1) designed to be a selective substrate of plasmin. D-Val-Leu-Lys-ara-C (2) was obtained by coupling the protected peptide Cbz-D-Val-Leu-(N6-Cbz)Lys-OH and ara-C (1) by a water-soluble carbodiimide (EDCI), followed by the removal of the Cbz groups by using catalytic hydrogenolysis over Pd/C. The kinetic constant of hydrolysis of 2 in the presence of plasmin demonstrated effective release of 1. The amino group of 1, which is sensitive to the removal by cytidine deaminase, is protected in 2 by the formation of the amide bond resulting in a prolonged half-life of 2 in biological milieu. The antiproliferative efficiency of 2 against L1210 leukemic cells was significantly higher than that of 1. The activity of 2 was abolished in the presence of serine proteinase inhibitor, (4-amidinopheny)methanesulfonyl fluoride. These data indicate that 2 is a prodrug form of 1 in systems generating plasmin.
引用
收藏
页码:3344 / 3349
页数:6
相关论文
共 24 条
[1]  
AOSHIMA M, 1977, CANCER RES, V37, P2481
[2]   EXPRESSION OF HUMAN RECOMBINANT PLASMINOGEN ACTIVATORS ENHANCES INVASION AND EXPERIMENTAL METASTASIS OF H-RAS-TRANSFORMED NIH 3T3 CELLS [J].
AXELROD, JH ;
REICH, R ;
MISKIN, R .
MOLECULAR AND CELLULAR BIOLOGY, 1989, 9 (05) :2133-2141
[3]   AN IMPROVED PREPARATION OF N-BENZYLOXYCARBONYL-L-LYSINE METHYL-ESTER HYDROCHLORIDE [J].
BALAJTHY, Z .
ORGANIC PREPARATIONS AND PROCEDURES INTERNATIONAL, 1991, 23 (03) :375-376
[4]  
BERGMANN SR, 1983, SCIENCE, V220, P1181
[5]  
BHUYAN BK, 1972, CANCER RES, V32, P398
[6]   PLASMINOGEN-ACTIVATOR IN NORMAL AND TUMOR-BEARING MICE [J].
BRUESCH, MR ;
JOHNSON, GL ;
PALACKDHARRY, CS ;
WEBER, MJ ;
CARL, PL .
INTERNATIONAL JOURNAL OF CANCER, 1983, 32 (01) :121-126
[7]   PLASMIN-ACTIVATED PRODRUGS FOR CANCER-CHEMOTHERAPY .1. SYNTHESIS AND BIOLOGICAL-ACTIVITY OF PEPTIDYLACIVICIN AND PEPTIDYLPHENYLENEDIAMINE MUSTARD [J].
CHAKRAVARTY, PK ;
CARL, PL ;
WEBER, MJ ;
KATZENELLENBOGEN, JA .
JOURNAL OF MEDICINAL CHEMISTRY, 1983, 26 (05) :633-638
[8]  
COLOWICK SP, 1978, METHOD ENZYMOL, V51, P394
[9]  
GERAN RI, 1972, CANC CHEMOTHER REP, V3, P1
[10]   SECRETION OF PLASMINOGEN ACTIVATOR BY HUMAN POLYMORPHONUCLEAR LEUKOCYTES - MODULATION BY GLUCOCORTICOIDS AND OTHER EFFECTORS [J].
GRANELLIPIPERNO, A ;
VASSALLI, JD ;
REICH, E .
JOURNAL OF EXPERIMENTAL MEDICINE, 1977, 146 (06) :1693-1706